- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00365430
SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes
SAFE or SORRY? Development and Testing of an Evidence Based Inpatient Safety Program for the Prevention of Common Complications.
Study Overview
Status
Intervention / Treatment
Detailed Description
Background Patients in hospitals and nursing homes are at risk for the development of, often preventable, somatic complications. However, preventive care is not always optimal. Although guidelines are available for many complications, compliance with the guidelines appears to be lacking. Besides general barriers that inhibit implementation, this non-compliance is also associated with the large number of guidelines competing for attention. As implementation of a guideline is time-consuming, organisations can never implement all available guidelines. Another problem is lack of feedback about performance using clear quality indicators and lack of a recognizable, unambiguous system for implementation.
Aim The aim of SAFE or SORRY? is to develop and test an evidence based inpatient safety program for the prevention of three frequently occuring adverse events: pressure ulcers, urinary tract infections and falls.
Participants Patients and nurses will be recruited from ten hospital wards and ten nursing home wards in the Netherlands. All nurses and all adult patients who are admitted for more than three days, will be asked for informed consent.
Method This study consists of two phases. In the first phase the program will be developed. The content of the program is based on the evidence based guidelines on pressure ulcers, urinary tract infections and falls. The program consists of a computerized registration and feedback system, an educational program for nurses and caregivers, and educational material for the patients.
In the second phase the program will be tested in a cluster randomised clinical trial. The program will be implemented on ten wards (5 hospital wards and 5 nursing home wards), i.e. the intervention group. The control group will continue to give care as usual.
Outcome measures Primary outcome measure: incidence of pressure ulcers, urinary tract infections and falls Secondary outcome measures: Utilization of preventive interventions and knowledge of nurses and caregivers regarding the complications and their prevention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gelderland
-
Arnhem, Gelderland, Netherlands, 6800 TA
- Alysis Zorggroep lokatie Rijnstate
-
Beneden-Leeuwen, Gelderland, Netherlands, 6658EK
- Zorggroep Maas en Waal
-
Nijmegen, Gelderland, Netherlands, 6500 HB
- Radboud University Nijmegen Medical Center
-
Nijmegen, Gelderland, Netherlands, 6500 GS
- Canisius Wilhelmina Ziekenhuis
-
Nijmegen, Gelderland, Netherlands, 6503 CB
- Stichting De Waalboog
-
Nijmegen, Gelderland, Netherlands, 6522 AS
- Zorggroep Zuid-Gelderland
-
Nijmegen, Gelderland, Netherlands, 6560 AB
- Universitair Longcentrum Dekkerswald
-
-
Noord-Brabant
-
Eindhoven, Noord-Brabant, Netherlands, 5616 PZ
- Stichting SVVE De Archipel
-
Geertruidenberg, Noord-Brabant, Netherlands, 4931 BP
- Stichting De Riethorst Stromenland
-
-
Noord-Limburg
-
Venlo, Noord-Limburg, Netherlands, 5900 AR
- Zorggroep Noord-Limburg Venlo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients on participating wards admitted for more than three days
- all nurses on participating wards
Exclusion Criteria:
- students on participating wards
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of adverse events (count incidence of Pressure Ulcers, Urinary Tract Infections, and Falls
Time Frame: nine months
|
nine months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Utilization of preventive interventions and knowledge of nurses and caregivers
Time Frame: nine months
|
nine months
|
Collaborators and Investigators
Investigators
- Study Director: Theo van Achterberg, PhD, Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud University Nijmegen Medical Center
Publications and helpful links
General Publications
- van Gaal BG, Schoonhoven L, Mintjes JA, Borm GF, Hulscher ME, Defloor T, Habets H, Voss A, Vloet LC, Koopmans RT, van Achterberg T. Fewer adverse events as a result of the SAFE or SORRY? programme in hospitals and nursing homes. part i: primary outcome of a cluster randomised trial. Int J Nurs Stud. 2011 Sep;48(9):1040-8. doi: 10.1016/j.ijnurstu.2011.02.017. Epub 2011 Mar 17.
- van Gaal BG, Schoonhoven L, Vloet LC, Mintjes JA, Borm GF, Koopmans RT, van Achterberg T. The effect of the SAFE or SORRY? programme on patient safety knowledge of nurses in hospitals and nursing homes: a cluster randomised trial. Int J Nurs Stud. 2010 Sep;47(9):1117-25. doi: 10.1016/j.ijnurstu.2010.02.001. Epub 2010 Mar 3.
- van Gaal BG, Schoonhoven L, Hulscher ME, Mintjes JA, Borm GF, Koopmans RT, van Achterberg T. The design of the SAFE or SORRY? study: a cluster randomised trial on the development and testing of an evidence based inpatient safety program for the prevention of adverse events. BMC Health Serv Res. 2009 Apr 1;9:58. doi: 10.1186/1472-6963-9-58.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SoS245119
- 54010002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.